FMP

FMP

Enter
API Tools
API DocumentationAPI Viewer
Pricing
Blog
How To
Education
Index ArticlesForexFinancial RatiosCryptoFinancial AnalysisOther
Market NewsDiscounted Cash FlowDeveloper
Screener
Most Searched StocksForeign Exchange RatesCryptocurrenciesMarket IndexesMarket Top GainersMarket Top LosersMarket Highest VolumeSector Performance
Extras
Resources
Formula Methodologies
Financial FormulasParsing StatementsDCF FormulaPiotroski ScoreOwner EarningsRecommendations Formula
Excel/Sheets Add-on
Excel Add-onGoogle Sheet Add-on
API Updates
ChangelogAPI StatusCycle Times
CareersAffiliate ProgramFAQs
Sign InSign Up

ENLV - Enlivex Th...

photo-url-https://images.financialmodelingprep.com/symbol/ENLV.png

Enlivex Therapeutics Ltd.

ENLV

NASDAQ

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

1.24 USD

0.06 (4.84%)

OverviewProfileFinancial StatementsFinancial RatiosChartAnalysisNewsCorporate ActionsDCF
page loading card
Operating DataBalance SheetFree Cash FlowFree Cash Flow BuildupTerminal ValueIntrinsic ValueEquity ValueWACC
FMP

FMP

FMP

HomeTerms of ServicePrivacy PolicyBlogCareersFAQsContact Us

API

DocumentationPricingFormulasMarket Indexes
Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep